ADVANCED SOLID TUMOURS
Clinical trials for ADVANCED SOLID TUMOURS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOURS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOURS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to shield heart while fighting tumors
Disease control Recruiting nowThis early-phase study tests a new drug called RC220 given with the chemotherapy doxorubicin in adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and see if RC220 can protect the heart from doxorubicin's sid…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Racura Oncology Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody drug aims to unleash immune system on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug, UCB4594, in people with advanced solid tumors that haven't responded to standard treatments. The drug is a monoclonal antibody that targets a protein called HLA-G on cancer cells, potentially helping the immune system attack them. The stud…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1, PHASE2 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug duo targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called PYX-201 combined with pembrolizumab in people with advanced solid tumors that have not responded to other treatments. The goal is to find safe doses and see if the combination can shrink tumors. About 220 adults with certain cancers like head an…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1, PHASE2 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo takes on advanced cancers in early human test
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called EBC-129, both by itself and together with the immunotherapy pembrolizumab, in people with advanced solid tumours that have stopped responding to standard treatments. The study will enroll about 98 adults and focus main…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cancer drug SIM0610 enters first human tests
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called SIM0610 in 260 adults with advanced solid tumors, including lung, colorectal, head and neck, and liver cancers. The main goals are to check the drug's safety, find the right dose, and see if it shrinks tumors. Particip…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-phase trial is testing a new drug called LM-168, alone or with the immunotherapy toripalimab, in 87 adults with advanced solid tumours that have not responded to standard treatments. The study first checks safety and the right dose, then looks for signs that the tumour…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC